The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Aerrane Market Research Report 2024

Global Aerrane Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1890213

No of Pages : 94

Synopsis
Aerrane(Isoflurane), sold under the trade name Forane among others, is a general anesthetic. It can be used to start or maintain anesthesia.
The global Aerrane market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Aerrane is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Aerrane is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Aerrane include Baxter, AbbVie, Halocarbon, Piramal Critical Care, Aesica Queenborough, Abbott Laboratories, Toronto Research Chemicals, Abcam and VetOne, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Aerrane, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Aerrane.
Report Scope
The Aerrane market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Aerrane market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Aerrane manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Baxter
AbbVie
Halocarbon
Piramal Critical Care
Aesica Queenborough
Abbott Laboratories
Toronto Research Chemicals
Abcam
VetOne
MedKoo Biosciences
JD Medical
Lunan Pharmaceutical
Segment by Type
Below 100ml
100-250ml
Above 250ml
Segment by Application
Hospital
Clinic
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Aerrane manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Aerrane in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Aerrane Market Overview
1.1 Product Overview and Scope of Aerrane
1.2 Aerrane Segment by Type
1.2.1 Global Aerrane Market Value Comparison by Type (2024-2030)
1.2.2 Below 100ml
1.2.3 100-250ml
1.2.4 Above 250ml
1.3 Aerrane Segment by Application
1.3.1 Global Aerrane Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Aerrane Market Size Estimates and Forecasts
1.4.1 Global Aerrane Revenue 2019-2030
1.4.2 Global Aerrane Sales 2019-2030
1.4.3 Global Aerrane Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Aerrane Market Competition by Manufacturers
2.1 Global Aerrane Sales Market Share by Manufacturers (2019-2024)
2.2 Global Aerrane Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Aerrane Average Price by Manufacturers (2019-2024)
2.4 Global Aerrane Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Aerrane, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Aerrane, Product Type & Application
2.7 Aerrane Market Competitive Situation and Trends
2.7.1 Aerrane Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Aerrane Players Market Share by Revenue
2.7.3 Global Aerrane Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Aerrane Retrospective Market Scenario by Region
3.1 Global Aerrane Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Aerrane Global Aerrane Sales by Region: 2019-2030
3.2.1 Global Aerrane Sales by Region: 2019-2024
3.2.2 Global Aerrane Sales by Region: 2025-2030
3.3 Global Aerrane Global Aerrane Revenue by Region: 2019-2030
3.3.1 Global Aerrane Revenue by Region: 2019-2024
3.3.2 Global Aerrane Revenue by Region: 2025-2030
3.4 North America Aerrane Market Facts & Figures by Country
3.4.1 North America Aerrane Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Aerrane Sales by Country (2019-2030)
3.4.3 North America Aerrane Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Aerrane Market Facts & Figures by Country
3.5.1 Europe Aerrane Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Aerrane Sales by Country (2019-2030)
3.5.3 Europe Aerrane Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Aerrane Market Facts & Figures by Country
3.6.1 Asia Pacific Aerrane Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Aerrane Sales by Country (2019-2030)
3.6.3 Asia Pacific Aerrane Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Aerrane Market Facts & Figures by Country
3.7.1 Latin America Aerrane Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Aerrane Sales by Country (2019-2030)
3.7.3 Latin America Aerrane Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Aerrane Market Facts & Figures by Country
3.8.1 Middle East and Africa Aerrane Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Aerrane Sales by Country (2019-2030)
3.8.3 Middle East and Africa Aerrane Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Aerrane Sales by Type (2019-2030)
4.1.1 Global Aerrane Sales by Type (2019-2024)
4.1.2 Global Aerrane Sales by Type (2025-2030)
4.1.3 Global Aerrane Sales Market Share by Type (2019-2030)
4.2 Global Aerrane Revenue by Type (2019-2030)
4.2.1 Global Aerrane Revenue by Type (2019-2024)
4.2.2 Global Aerrane Revenue by Type (2025-2030)
4.2.3 Global Aerrane Revenue Market Share by Type (2019-2030)
4.3 Global Aerrane Price by Type (2019-2030)
5 Segment by Application
5.1 Global Aerrane Sales by Application (2019-2030)
5.1.1 Global Aerrane Sales by Application (2019-2024)
5.1.2 Global Aerrane Sales by Application (2025-2030)
5.1.3 Global Aerrane Sales Market Share by Application (2019-2030)
5.2 Global Aerrane Revenue by Application (2019-2030)
5.2.1 Global Aerrane Revenue by Application (2019-2024)
5.2.2 Global Aerrane Revenue by Application (2025-2030)
5.2.3 Global Aerrane Revenue Market Share by Application (2019-2030)
5.3 Global Aerrane Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Baxter
6.1.1 Baxter Corporation Information
6.1.2 Baxter Description and Business Overview
6.1.3 Baxter Aerrane Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Baxter Aerrane Product Portfolio
6.1.5 Baxter Recent Developments/Updates
6.2 AbbVie
6.2.1 AbbVie Corporation Information
6.2.2 AbbVie Description and Business Overview
6.2.3 AbbVie Aerrane Sales, Revenue and Gross Margin (2019-2024)
6.2.4 AbbVie Aerrane Product Portfolio
6.2.5 AbbVie Recent Developments/Updates
6.3 Halocarbon
6.3.1 Halocarbon Corporation Information
6.3.2 Halocarbon Description and Business Overview
6.3.3 Halocarbon Aerrane Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Halocarbon Aerrane Product Portfolio
6.3.5 Halocarbon Recent Developments/Updates
6.4 Piramal Critical Care
6.4.1 Piramal Critical Care Corporation Information
6.4.2 Piramal Critical Care Description and Business Overview
6.4.3 Piramal Critical Care Aerrane Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Piramal Critical Care Aerrane Product Portfolio
6.4.5 Piramal Critical Care Recent Developments/Updates
6.5 Aesica Queenborough
6.5.1 Aesica Queenborough Corporation Information
6.5.2 Aesica Queenborough Description and Business Overview
6.5.3 Aesica Queenborough Aerrane Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Aesica Queenborough Aerrane Product Portfolio
6.5.5 Aesica Queenborough Recent Developments/Updates
6.6 Abbott Laboratories
6.6.1 Abbott Laboratories Corporation Information
6.6.2 Abbott Laboratories Description and Business Overview
6.6.3 Abbott Laboratories Aerrane Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Abbott Laboratories Aerrane Product Portfolio
6.6.5 Abbott Laboratories Recent Developments/Updates
6.7 Toronto Research Chemicals
6.6.1 Toronto Research Chemicals Corporation Information
6.6.2 Toronto Research Chemicals Description and Business Overview
6.6.3 Toronto Research Chemicals Aerrane Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Toronto Research Chemicals Aerrane Product Portfolio
6.7.5 Toronto Research Chemicals Recent Developments/Updates
6.8 Abcam
6.8.1 Abcam Corporation Information
6.8.2 Abcam Description and Business Overview
6.8.3 Abcam Aerrane Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Abcam Aerrane Product Portfolio
6.8.5 Abcam Recent Developments/Updates
6.9 VetOne
6.9.1 VetOne Corporation Information
6.9.2 VetOne Description and Business Overview
6.9.3 VetOne Aerrane Sales, Revenue and Gross Margin (2019-2024)
6.9.4 VetOne Aerrane Product Portfolio
6.9.5 VetOne Recent Developments/Updates
6.10 MedKoo Biosciences
6.10.1 MedKoo Biosciences Corporation Information
6.10.2 MedKoo Biosciences Description and Business Overview
6.10.3 MedKoo Biosciences Aerrane Sales, Revenue and Gross Margin (2019-2024)
6.10.4 MedKoo Biosciences Aerrane Product Portfolio
6.10.5 MedKoo Biosciences Recent Developments/Updates
6.11 JD Medical
6.11.1 JD Medical Corporation Information
6.11.2 JD Medical Aerrane Description and Business Overview
6.11.3 JD Medical Aerrane Sales, Revenue and Gross Margin (2019-2024)
6.11.4 JD Medical Aerrane Product Portfolio
6.11.5 JD Medical Recent Developments/Updates
6.12 Lunan Pharmaceutical
6.12.1 Lunan Pharmaceutical Corporation Information
6.12.2 Lunan Pharmaceutical Aerrane Description and Business Overview
6.12.3 Lunan Pharmaceutical Aerrane Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Lunan Pharmaceutical Aerrane Product Portfolio
6.12.5 Lunan Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Aerrane Industry Chain Analysis
7.2 Aerrane Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Aerrane Production Mode & Process
7.4 Aerrane Sales and Marketing
7.4.1 Aerrane Sales Channels
7.4.2 Aerrane Distributors
7.5 Aerrane Customers
8 Aerrane Market Dynamics
8.1 Aerrane Industry Trends
8.2 Aerrane Market Drivers
8.3 Aerrane Market Challenges
8.4 Aerrane Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’